Skip to main content
Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
258.65
+4.96 (1.96%)
At close: Mar 9, 2026, 4:00 PM EDT
263.82
+5.17 (2.00%)
After-hours: Mar 9, 2026, 4:53 PM EDT

Krystal Biotech Revenue

In the year 2025, Krystal Biotech had annual revenue of $389.13M with 33.94% growth. Krystal Biotech had revenue of $107.11M in the quarter ending December 31, 2025, with 17.52% growth.

Revenue (ttm)
$389.13M
Revenue Growth
+33.94%
P/S Ratio
19.11
Revenue / Employee
$1,319,085
Employees
295
Market Cap
7.56B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025389.13M98.62M33.94%
Dec 31, 2024290.52M239.82M473.02%
Dec 31, 202350.70M--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Halozyme Therapeutics 1.40B
Arrowhead Pharmaceuticals 1.09B
Axsome Therapeutics 638.50M
Cytokinetics 88.04M
Kymera Therapeutics 39.21M
Arcellx 22.29M
Praxis Precision Medicines 7.46M
ABIVAX Société Anonyme 6.23M
Revenue Rankings

KRYS News

More News